These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3398988)

  • 1. How much heparin intraperitoneally is necessary in CAPD?
    Gries E; Paar D; Graben N; Bock KD
    Nephron; 1988; 49(3):256. PubMed ID: 3398988
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intraperitoneal administration of heparin to patients on continuous ambulatory peritoneal dialysis (CAPD).
    Takahashi S; Shimada A; Okada K; Kuno T; Nagura Y; Hatano M
    Perit Dial Int; 1991; 11(1):81-3. PubMed ID: 2049431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal heparin in CAPD.
    Gries E; Graben N; Bock KD; Paar D
    Life Support Syst; 1985; 3 Suppl 1():125-30. PubMed ID: 3870551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
    Nevalainen P; Lahtela J; Mustonen J; Pasternack A
    Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraperitoneal fibrin-formation and its inhibition in CAPD.
    Gries E; Paar D; Graben N; Bock KD
    Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin induced thrombocytopaenia secondary to intraperitoneal heparin exposure.
    Kaplan GG; Manns B; McLaughlin K
    Nephrol Dial Transplant; 2005 Nov; 20(11):2561-2. PubMed ID: 16014345
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of intraperitoneal administration of low-molecular-weight heparin on plasma tissue factor pathway inhibitor levels in CAPD patients.
    Demirkan F; Akarsu M; Sifil A; Tutucu KN
    Nephron; 2002 May; 91(1):162-3. PubMed ID: 12021535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis (CAPD).
    Mulgaonkar S; Lyman N; Viscuso R; Jacobs MG
    J Med Soc N J; 1983 Jun; 80(6):427-30. PubMed ID: 6577192
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effect of heparin and/or antithrombin III on intraperitoneal fibrin formation in continuous ambulatory peritoneal dialysis.
    Tabata T; Shimada H; Emoto M; Morita A; Furumitsu Y; Fujita J; Inoue T; Miki T; Nishizawa Y; Morii H
    Nephron; 1990; 56(4):391-5. PubMed ID: 2079997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peritoneal transport of amino acids in continuous ambulatory peritoneal dialysis (CAPD)].
    Olszowska A; Baczyński D
    Pol Arch Med Wewn; 1999 Jul; 102(1):629-33. PubMed ID: 10835926
    [No Abstract]   [Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
    Montañés Pauls B; Almiñana MA; Casabó Alós VG
    Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Own modification of the visualization of adhesions in the peritoneal cavity in patients treated with continuous ambulatory peritoneal dialysis].
    Pietrzak B
    Pol Arch Med Wewn; 1999 Jul; 102(1):583-8. PubMed ID: 10835919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous ambulatory peritoneal dialysis in diabetic patients].
    Stojimrović B; Nesić V
    Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical problems in continuous ambulatory peritoneal dialysis (CAPD).
    Mallonga ET; van Coevorden F; Boeschoten EW; Southwood J; Krediet RT
    Neth J Surg; 1982 Jul; 34(3):117-22. PubMed ID: 7121871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What brought us CAPD (continuous ambulatory peritoneal dialysis)? (author's transl)].
    Colombi A
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):309-12. PubMed ID: 7071046
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
    Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal application of low-molecular-weight heparin in continuous ambulatory peritoneal dialysis in a child.
    Kleta R; Fründ S; Kuwertz-Bröking E; Bulla M
    Nephron; 2000 Dec; 86(4):545. PubMed ID: 11124625
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effective automated peritoneal dialysis for patients with average to low transport.
    Newman LN; Hanslik TM; Tessman M
    ANNA J; 1994 Aug; 21(5):271-3. PubMed ID: 8080339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients.
    Sifil A; Mermut C; Yenicerioglu Y; Cavdar C; Gumustekin M; Celik A; Yuksel F; Camsari T
    Adv Perit Dial; 2003; 19():28-30. PubMed ID: 14763030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
    Ragnaud JM; Roche-Bezian MC; Dupon M; Wone C
    Chemioterapia; 1987 Jun; 6(2 Suppl):481-3. PubMed ID: 3509476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.